TECENTRIQ is a prescription medicine used to treat adults with: A type of bladder and urinary tract cancer called urothelial carcinoma. A type of lung cancer called non-small cell lung cancer (NSCLC). A type of breast cancer called triple-negative breast cancer (TNBC). A type of lung cancer called small cell lung cancer (SCLC).
Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), small cell lung cancer (SCLC), and hepatocellular carcinoma (HCC). It is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1).
Please call on +91 9910645395 (Mr. Rakesh) or email your enquiry at Verve Biosciences to find the price of TECENTRIQ (atezolizumab) Injection in UK, Europe, Middle Eastern countries, Vietnam, Philippines, Ireland and Africa. We take guarantee of quality and delivery as per the buyer’s requirements.
To buy TECENTRIQ (atezolizumab) Injection in India, request you to send your details via query form or you can call or WhatsApp (+91) 9910645395 or send mail to urgent@cancermedicinesnetwork.com to know the best price. We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Yes, Verve Biosciences can assist in the delivery of TECENTRIQ (atezolizumab) Injection, doctor prescribed medicine. The Order Will Be Confirmed Only After The Receipt Of Valid prescription of Doctor and Import permit if applicable.
Verve Biosciences have exported TECENTRIQ (atezolizumab) Injection in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.